Frontier Capital Management’s Veradermics MANE Stock Holding History
Bought
Maintained
Sold
Other funds holding MANE
SL
Frontier Capital Management's MANE Position: Q3 2026 in Review
Frontier Capital Management reduced its Veradermics (MANE) stake by 64% in Q3 2026, selling an estimated $17.8M and leaving 92,174 shares worth $11.2M. The position accounts for 0.12% of the portfolio, ranked #221.
Frontier Capital Management first reported a position in MANE in Q2 2026 and has held it in 2 quarters since. The position peaked at $31.3M in Q2 2026. 208 funds tracked by Wall St. Rank hold MANE as of Q3 2026.
- Frontier Capital Management held 92,174 shares of Veradermics worth $11.2M as of Q3 2026.
- Frontier Capital Management sold 162,702 Veradermics shares in Q3 2026, an estimated $17.8M.
- Veradermics made up 0.12% of Frontier Capital Management's portfolio in Q3 2026, its #221 holding.
- Frontier Capital Management first reported a position in Veradermics in Q2 2026 and has held it in 2 quarters since.
- Frontier Capital Management's Veradermics position peaked at $31.3M in Q2 2026.
- 208 funds tracked by Wall St. Rank held Veradermics as of Q3 2026.
Based on Frontier Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.